Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids
Open accessThe DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Abstract
Taking into consideration that glucocorticoid (GC) hormones have been used clinically for over half a century and that more than 20 yr have passed since the cloning of the GC receptor (GR), it is hard to imagine that novel aspects in the molecular mechanism by which GCs mediate their antiinflammatory actions are still being unveiled today. Partly, this is because almost on a daily basis, novel insights arise from parallel fields, e.g. nuclear receptor cofactor and chromatin regulation and their concomitant impact on gene transcription events, eventually leading to a revisitation or refinement of old hypotheses. On the other hand, it does remain striking and puzzling why GCs use different mechanisms in so many different cell types and on many different target genes to elicit an antiinflammatory effect. Meanwhile, the obvious question for the clinic remains: is the separation of GR functionalities through differential ligand design the strategy of choice to avoid most GC-mediated side effects? This minireview aims to highlight some of the latest findings on aspects of the antiinflammatory working mechanisms of GCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A failure in GR function, as hypothesized to take place in depression, may therefore result from reduced glucocorticoid binding to GR, reduced GR expression, enhanced activation of inflammatory pathways, or lack of co-repressor activity”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as De Bosscher and Haegeman, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Jonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
Schüle, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., & Evans, R. M. (1990) · Cell · doi:10.1016/0092-8674(90)90397-w · Cited by 1,221
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Cited by
Items 101–200 of 288
Sarcoidosis Increases Risk of Hospitalized Infection. A Population-based Study, 1976–2013
Ungprasert, P., Crowson, C. S., & Matteson, E. L. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201610-750oc · Cited by 34
Ouabain attenuates ovalbumin-induced airway inflammation
Galvão, J. G. F. M., Silva, L. H. A. C., Carvalho, D. C. M., Ferreira, L. K. D. P., Monteiro, T. M., Alves, A. F., Ferreira, L. A. M. P., Gadelha, F. A. A. F., Piuvezam, M. R., & Rodrigues‐Mascarenhas, S. (2017) · Inflammation Research · doi:10.1007/s00011-017-1092-9 · Cited by 35
Structure of the Glucocorticoid Receptor, a Flexible Protein That Can Adapt to Different Ligands
Veleiro, A. S., Álvarez, L. D., Eduardo, S. L., & Burton, G. (2010) · ChemMedChem · doi:10.1002/cmdc.201000014 · Cited by 37
Catecholamines, Steroids and Immune Alterations in Ischemic Stroke and Other Acute Diseases
Schulze, J., Vogelgesang, A., & Dressel, A. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500327 · Cited by 39
“As a dimer, GCR binds the glucocorticoid response element, when undimerized, GCR binds pro-inflammatory transcription factors such as AP-1, NF-kB, IRF-3, STAT, CREB, NFAT, T-bet, and GATA-3, leading to their inhibition [27].”
BackgroundSelective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice
Huynh, T., Uaesoontrachoon, K., Quinn, J. L., Tatem, K. S., Heier, C. R., van der Meulen, J. H., Yu, Q., Harris, M. A., Nolan, C. J., Haegeman, G., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4231 · Cited by 37
“to GC-bound GR dimer interactions with GC response elements (GRE) mediating the transcription of the relevant genes (transactivation) [7].”
BackgroundSelf-citationKeenan, C. R., Radojicic, D., Li, M., Radwan, A. M., & Stewart, A. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.006 · Cited by 39
Hernández-Pérez, J., Naderi, F., Chivite, M., Soengas, J. L., Míguez, J. M., & López‐Patiño, M. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00611 · Cited by 40
“Transcription of target genes can be also activated by other transcription factors, nuclear factor-κB (NF-κB), activator protein-1 (AP-1), or STAT5 (Scheinman et al., 1995; Garside et al., 2004; Kino and Chrousos, 2004; Chrousos and Kino, 2005; De Bosscher and Haegeman, 2009).”
BackgroundCortisol treatment of prespawning female cod affects cytogenesis related factors in eggs and embryos
Kleppe, L., Karlsen, Ø., Edvardsen, R. B., Norberg, B., Andersson, E., Taranger, G. L., & Wargelius, A. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.04.028 · Cited by 35
“…glucocorticoid receptor into the nucleus takes place in response to the binding of cortisol; in the nucleus this receptor recruits regulatory cofactor complexes and subsequently binds to glucocorticoidresponsive elements in the DNA and affects gene transcription (De Bosscher and Haegeman, 2009).”
BackgroundRoach, S. L., Higuchi, R. I., Adams, M. E., Liu, Y., Karanewsky, D. S., Marschke, K. B., Mais, D. E., Miner, J. N., & Zhi, L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.05.029 · Cited by 35
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments
Sundahl, N., Clarisse, D., Bracke, M., Offner, F. C., Berghe, W. V., & Beck, I. M. E. (2016) · Oncoscience · doi:10.18632/oncoscience.315 · Cited by 35
“Despite its widespread use, chronic exposure to GCs in cancer treatments is severely limited by the vast range of side effects it induces or the development of therapy resistance [2].”
BackgroundMolecular determinants of glucocorticoid actions in inflammatory joint diseases
Baschant, U., Culemann, S., & Tuckermann, J. P. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.009 · Cited by 31
Pang, J., Hu, X., Wang, Y., Liao, J., Chai, X., Wang, X., Shen, C., Wang, J., Zhang, L., Wang, X., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00855-6 · Cited by 29
Cuello‐García, C. A., Roldán-Benítez, Y. M., Gaxiola, G. P., & Villarreal-Careaga, J. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.12.010 · Cited by 27
“Corticosteroids are immunomodulatory hormones that are known to inhibit the proliferation of the inflammatory response.(8,9) Their use in patients with neurocysticercosis followed clinical observations of side effects associated with the initiation of anthelmintic therapies.”
BackgroundGlucocorticoid receptor: implications for rheumatic diseases.
Kino, T., Charmandari, E., & Chrousos, G. P. (2011) · Clinical and Experimental Rheumatology · Cited by 32
Human lymphocyte activation assay: Anin vitromethod for predictive immunotoxicity testing
Collinge, M., Cole, S. H., Schneider, P. A., Donovan, C. B., Kamperschroer, C., & Kawabata, T. T. (2010) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.523881 · Cited by 27
“The anti-inflammatory actions of glucocorticoids, including dexamethasone, are primarily attributable to the suppression of factors essential for transcription of cytokines and chemokine mRNAs (De Bosscher and Haegeman, 2009).”
BackgroundCheng, M.-X., Chen, Z.-Z., Cai, Y., Liu, C.-A., & Tu, B. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.02.066 · Cited by 27
Reuter, K. C., Loitsch, S. M., Dignass, A. U., Steinhilber, D., & Stein, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029756 · Cited by 31
“Thus, a promising new therapeutic approach based on the selective modulation of GR action and a new class of synthetic agents, the selective GR agonists (SEGRAs), aims to combine anti-inflammatory action with simultaneous reduction of adverse effects [9] [11,12].”
BackgroundSpeca, S., Dubuquoy, L., & Desreumaux, P. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000253 · Cited by 25
The AGC Kinase Inhibitor H89 Attenuates Airway Inflammation in Mouse Models of Asthma
Reber, L. L., Daubeuf, F., Nemska, S., & Frossard, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049512 · Cited by 27
“Indeed, the efficiency of corticosteroids is based on repression of many transcription factors [10].”
BackgroundProdrug approach to improve absorption of prednisolone
Ye, S., Yang, X., Pal, D., & Mitra, A. K. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.029 · Cited by 24
“E-mail address: mitraa@umkc.edu (A.K. Mitra). http://dx.doi.org/10.1016/j.ijpharm.2015.04.029 0378-5173/ã 2015 Published by Elsevier B.V. Bosscher and Haegeman, 2009).”
InfluentialBaiula, M., Spartà, A., Bedini, A., Carbonari, G., Bucolo, C., Ward, K. W., Zhang, J., Govoni, P., & Spampinato, S. M. (2011) · PubMed Central · Cited by 27
Cortisol and proinflammatory cytokine profiles in type 1 (reversal) reactions of leprosy
Vedithi, S. C., Lavania, M., Nigam, A., Turankar, R. P., Singh, I., Horo, I., Sengupta, U., & Jadhav, R. S. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.10.008 · Cited by 31
Bansal, A., Mostafa, M., Kooi, C., Sasse, S. K., Michi, A. N., Shah, S., Leigh, R., Gerber, A. N., & Newton, R. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101747 · Cited by 26
“However, ligand-activated GR may also interact with inflammatory transcription factors, such as nuclear factor (NF)-κB and AP-1, and this is suggested to directly promote transcriptional repression (12).”
BackgroundLatorre, V., Sevilla, L. M., Sanchís, A., & Pérez, P. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.255 · Cited by 23
Dezitter, X., Fagart, J., Taront, S., Fay, M., Masselot, B., Hétuin, D., Formstecher, P., Rafestin-Oblin, M. E., & Idziorek, T. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085860 · Cited by 27
Sales‐Campos, H., de Souza, P. R., Basso, P. J., Nardini, V., Silva, A., Banquieri, F., Alves, V. B. F., Chica, J. E. L., Nomizo, A., & Cardoso, C. R. D. B. (2016) · Immunology · doi:10.1111/imm.12672 · Cited by 22
Bougarne, N., Mylka, V., Ratman, D., Beck, I. M. E., Thommis, J., Cauwer, L. D., Tavernier, J. H., Staels, B., Libert, C., & Bosscher, K. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01769 · Cited by 24
Meers, C. M. F., Wauters, S., Verbeken, E. K., Scheers, H., Vanaudenaerde, B. M., Verleden, G. M., & Raemdonck, D. E. V. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.05.062 · Cited by 21
“It is well known that the therapeutic effect of steroids is not observed immediately as the drug interferes with cellular transcription factors leading to inhibition of pro-inflammatory cytokines [31].”
BackgroundLuo, M., & Simons, S. S. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.07.029 · Cited by 20
“Initially it was thought that these properties of glucocorticoid receptors (GRs) involve gene repression but it is now clear that GR-induced responses are also required (2,3).”
BackgroundBetageri, R., Gilmore, T., Kuzmich, D., Kirrane, T. M., Bentzien, J., Wiedenmayer, D., Bekkali, Y., Regan, J. R., Berry, A. K., Latli, B., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.018 · Cited by 20
Chatzopoulou, A., Schoonheim, P. J., Torraca, V., Meijer, A. H., Spaink, H. P., & Schaaf, M. J. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.036 · Cited by 22
Mitchell, M. C., & Szabó, G. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch26 · Cited by 19
A novel strategy for development of glucocorticoids through non-genomic mechanism
Zhou, J., Li, M., Sheng, C., Liu, L., Li, Z., Wang, Y., Zhou, J., Jing, Z., Chen, Y., & Jiang, C. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0526-0 · Cited by 20
“It is assumed that transrepression of transcription factors such as AP-1 and NF-kappa B is the main mechanism by which GCs mediate their antiinflammatory activity, whereas the side effects of GCs are mainly mediated by GR-DNA-interaction either by activation or by negative regulation of gene expression (reviewed in [1…”
Baicalein Is a Phytohormone that Signals Through the Progesterone and Glucocorticoid Receptors
Austin, J. R., Kirkpatrick, B. J., Rodríguez, R. R., Johnson, M. E., Lantvit, D. D., & Burdette, J. E. (2020) · Hormones and Cancer · doi:10.1007/s12672-020-00382-6 · Cited by 19
Hosseini, S. H., Maleki, A., Eshraghi, H. R., & Hamidi, M. (2016) · Drug Delivery · doi:10.3109/10717544.2016.1138341 · Cited by 21
“The drug generates anti-inFammatory effects by binding to glucocorticoid receptors, thus triggering signal transduction pathways (De Bosscher & Haegeman, 2009).”
BackgroundEffects of glucocorticoid on the eye development in guinea pigs
Ding, M., Guo, D., Wu, J., Ye, X., Zhang, Y., Sha, F., Jiang, W., & Bi, H. (2018) · Steroids · doi:10.1016/j.steroids.2018.09.008 · Cited by 16
“, osteoporosis, hypertension, diabetes mellitus, atrophy of skin and muscle, glaucoma, cataracts, and increased susceptibility to infections [5,6].”
Burke, S. J., Batdorf, H. M., Huang, T.-Y., Jackson, J. W., Jones, K. A., Martin, T. M., Rohli, K. E., Karlstad, M. D., Sparer, T. E., Burk, D. H., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105468 · Cited by 19
“Glucocorticoids are widely prescribed anti-inflammatory molecules with potent metabolic side effects [31, 32].”
Turan, A., Dalton, J. E., Turner, P. L., Sessler, D. I., Kurz, A. M., & Saager, L. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181e6a195 · Cited by 18
“And finally, it is widely recognized that glucocorticoids suppress immune responses by decreasing leukocyte migration(25) and by inhibiting synthesis of proinflammatory cytokines.(26) Consistent with previous reports, we observed a significant increase in both systemic and wound infection: steroid users were 24% more…”
BackgroundTherapeutic Interventions to Enhance Apolipoprotein A-I-Mediated Cardioprotection
Haas, M. J., & Mooradian, A. D. (2010) · Drugs · doi:10.2165/11535410-000000000-00000 · Cited by 17
“It is also possible that GR binds to the apo A-I promoter at a site that diverges from a simple glucocorticoid response element (GRE) palindrome such as a composite GRE.”
BackgroundOasa, S., Sasaki, A., Yamamoto, J., Mikuni, S., & Kinjo, M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.003 · Cited by 19
“Previous studies have reported proteins interacting with GR such as Hsp90 and cofactors [21,22,23].”
BackgroundCazzola, M., Rogliani, P., Calzetta, L., & Matera, M. G. (2020) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s231471 · Cited by 25
Kino, T., Pavlatou, M. G., Moraitis, A. G., Nemery, R., Raygada, M. J., & Stratakis, C. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3493 · Cited by 17
Estrogen signaling through both membrane and nuclear receptors in the liver of fathead minnow
García‐Reyero, N., Jayasinghe, B. S., Kroll, K. J., Sabo‐Attwood, T., & Denslow, N. D. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.07.019 · Cited by 17
Cechin, S. R., & Buchwald, P. (2014) · Steroids · doi:10.1016/j.steroids.2014.04.003 · Cited by 18
“This sensor cell line was generated by stable transfection of HEK293 cells with the human CD40 gene and an NF-κB-inducible SEAP construct, which consists of the SEAP reporter gene under the control of the IFN-β minimal promoter fused to five NF-κB (and five AP-1) binding sites.”
BackgroundInfluentialShnayder, N. A., Ashkhotov, A. V., Trefilova, V. V., Nurgaliev, Z. A., Novitsky, M. A., Петрова, М. М., Narodova, E. A., Al-Zamil, M., Chumakova, G. A., Garganeeva, N. P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097692 · Cited by 21
Interference of Boswellic Acids with the Ligand Binding Domain of the Glucocorticoid Receptor
Scior, T., Verhoff, M., Gutierrez-Aztatzi, I., Ammon, H. P. T., Laufer, S., & Werz, O. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400666a · Cited by 17
Novel glucocorticoid receptor agonists in the treatment of asthma
Cazzola, M., Coppola, A., Rogliani, P., & Matera, M. G. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1078310 · Cited by 16
“The clinical efficacy of synthetic exogenous GCs as effective anti-inflammatory agents is largely attributed to their ability to reduce the expression of pro-inflammatory genes, via activation of the GRs and the concomitant inhibition of the activity of pro-inflammatory transcription factors, including NF-kB and activ…”
BackgroundTrusca, V. G., Fuior, E. V., Fenyo, I. M., Kardassis, D., Simionescu, M., & Gafencu, A. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174078 · Cited by 15
A proposed role for glucocorticoids in mediating dopamine-dependent cue-reward learning
Lopez, S. A., & Flagel, S. B. (2020) · Stress · doi:10.1080/10253890.2020.1768240 · Cited by 17
“Beyond the stress response, glucocorticoid function has been implicated in metabolism (Rose et al., 2010; Vegiopoulos & Herzig, 2007), inflammation (De Bosscher & Haegeman, 2009; Scheschowitsch et al., 2017), immune response (Cain & Cidlowski, 2017), development (Busada & Cidlowski, 2017; De Kloet…”
BackgroundModulation of the Glucocorticoid Receptor Activity by Post-Translational Modifications
Liberman, A. C., Antunica-Noguerol, M., & ARZT, E. S. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101086 · Cited by 18
“When binding to its ligand, GR undergoes a conformational change that promotes its translocation to the nucleus and the recruitment of regulatory cofactor complexes finally impacting gene transcription [38].”
Liu, Y., Jang, S., Wang, S., Chen, C.-H., & Li, F. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1074113 · Cited by 13
“…the crystal structures of various GR–ligand complexes and exploring the structural diversity of GR ligands, numerous pharmaceutical efforts toward the development of so-called dissociated GCs have increased preference for tethering TR over TA (De Bosscher & Haegeman, 2009; Schäcke et al., 2004).”
BackgroundPrednisolone-Induced Changes in Gene-Expression Profiles in Healthy Volunteers
Toonen, E. J. M., Fleuren, W., Nässander, U. K., van Lierop, M.-J. C., Bauerschmidt, S., Dokter, W. H. A., & Alkema, W. B. L. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.34 · Cited by 15
Saliu, T. P., Kumrungsee, T., Miyata, K., Tominaga, H., Yazawa, N., Hashimoto, K., Kamesawa, M., & Yanaka, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120183 · Cited by 14
Singh, M., Agarwal, V., Jindal, D., Pancham, P., Agarwal, S., Mani, S., Tiwari, R. K., Das, K., Alghamdi, B. S. A., Abujamel, T. S., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13030337 · Cited by 18
Alonso, M. R., Anesini, C. A., & Martino, R. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-78274-4_14 · Cited by 15
Design of small molecules targeting transcriptional activation by NF-κB: overview of recent advances
Straus, D. S. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903143739 · Cited by 13
“Rather, it results from protein–protein interactions between the nuclear receptor and NF-κB itself or NF-κB-associated corepressor or co-activator complexes (reviewed recently in [52,53]).”
BackgroundRoach, S. L., Higuchi, R. I., Hudson, A. R., Adams, M. E., Syka, P. M., Mais, D. E., Miner, J. N., Marschke, K. B., & Zhi, L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.047 · Cited by 12
Orqueda, A. J., Dansey, M. V., Español, A. J., Veleiro, A. S., Joffé, E. B. D. K., Sales, M. E., Burton, G., & Pecci, A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.04.006 · Cited by 15
“In the case of GCs, recent advances in the study of the molecular mechanisms of GR action, together with simulation of the ligand interaction with the tertiary structure of the GR ligand binding domain by molecular dynamics, have promoted increasing interest in the development of dissociated GR modulators that can alt…”
BackgroundNovel insights into the neuroendocrine control of inflammation: the role of GR and PARP1
Aprile-Garcia, F., Antunica-Noguerol, M., Budziñski, M. L., Liberman, A. C., & ARZT, E. S. (2013) · Endocrine Connections · doi:10.1530/ec-13-0079 · Cited by 16
Oasa, S., Mikuni, S., Yamamoto, J., Kurosaki, T., Yamashita, D., & Kinjo, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25393-w · Cited by 13
Neural Pathways in Allergic Inflammation
Mirotti, L. C., Castro, J., Costa‐Pinto, F. A., & Russo, M. (2010) · Journal of Allergy · doi:10.1155/2010/491928 · Cited by 13
Eirefelt, S., Stahlhut, M., Svitacheva, N., Carnerup, M. A., da Rosa, J. C., Ewald, D. A., Marstrand, T. T., Krogh-Madsen, M., Dünstl, G., Dack, K. N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05471-w · Cited by 14
Glucocorticoid receptor antagonizes EGFR function to regulate eyelid development
Sanchís, A., Bayo, P., Sevilla, L. M., & Pérez, P. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103071as · Cited by 14
Yang, L.-M., Chang, S., Lin, W.-K., Chou, B.-H., Wang, L., Liu, P.-C., & Lin, S. (2012) · Phytochemistry · doi:10.1016/j.phytochem.2011.12.006 · Cited by 11
Gorbacheva, A. M., Kuprash, D. V., & Mitkin, N. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123956 · Cited by 14
“However, available data on the specific GR-DNA interactions in the GR target genes are rather limited and poorly defined [44,46,47].”
BackgroundTherapeutic utility of glucocorticoids and antihistamines cotreatment. Rationale and perspectives
Zappia, C. D., & Monczor, F. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.530 · Cited by 14
Glucocorticoid-induced ocular hypertension: origins and new approaches to minimize
Yorio, T., Patel, G. C., & Clark, A. F. (2020) · Expert Review of Ophthalmology · doi:10.1080/17469899.2020.1762488 · Cited by 9
Cacheiro‐Llaguno, C., Hernández-Subirá, E., Díaz‐Muñoz, M. D., Fresno, M., Serrador, J. M., & Iñiguez, M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113275 · Cited by 13
“Therefore, additional mechanisms mediating GC-GR transrepression, such as competition with coactivators, as well as interference with kinase-activating cascades [22,74,75], could explain the interference with transcription factor TADs.”
BackgroundKaragiannopoulos, A., Westholm, E., Ofori, J. K., Cowan, E., Esguerra, J. L. S., & Eliasson, L. (2023) · iScience · doi:10.1016/j.isci.2023.106555 · Cited by 14
“Furthermore, a significantly higher number of GREs were detected closer to upregulated or downregulated DE genes than non-DE genes, supporting a role of GR as both an activator and repressor of gene expression.(49,50) It was also apparent from our data that GR binding was more strongly associated with the induced rath…”
ResultLong-Lasting Impact of Early Life Immune Stress on Neuroimmune Functions
Mouihate, A. (2013) · Medical Principles and Practice · doi:10.1159/000354199 · Cited by 10
Alcoholic Hepatitis: Steroids vs. Pentoxifylline
Smart, L., Gobejishvili, L., Crittenden, N. E., Barve, S. S., & McClain, C. J. (2013) · Current Hepatology Reports · doi:10.1007/s11901-012-0158-y · Cited by 10
“Research suggests that steroid non-responding AH patients have a 6-month mortality of approximately 60 % [7, 8].”
BackgroundOkamoto, K., Hirata‐Tsuchiya, S., Kitamura, C., Omoteyama, K., Sato, T., Arito, M., Kurokawa, M. S., Suematsu, N., & Kato, T. (2016) · Endocrinology · doi:10.1210/en.2016-1746 · Cited by 10
A patent review of anticancer glucocorticoid receptor modulators (2014-present)
Lucafò, M., Franzin, M., Decorti, G., & Stocco, G. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1740206 · Cited by 10
Zhang, T., Jiang, Q., Xu, F., Zhang, R., Liu, D., Guo, D., Wu, J., Wen, Y., Wang, X., Jiang, W., et al. (2021) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2020.579769 · Cited by 12
Molecular Cross-Talk Between Nuclear Receptors and Nuclear Factor-κB
Beck, I. M. E., Haegeman, G., & Bosscher, K. D. (2010) · Springer eBooks · doi:10.1007/978-90-481-9531-2_10 · Cited by 9
Self-citationLiberman, A. C., Refojo, D., Antunica-Noguerol, M., Holsboer, F., & ARZT, E. S. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.01.008 · Cited by 11
Prednisolone induces the Wnt signalling pathway in 3T3-L1 adipocytes
Fleuren, W., Linssen, M. M. L., Toonen, E. J. M., van der Zon, G. C. M., Guigas, B., de Vlieg, J., Dokter, W. H. A., Ouwens, D. M., & Alkema, W. B. L. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.774022 · Cited by 10
“…is hampered because of adverse (metabolic) side effects, such as insulin resistance, glucose intolerance, diabetes, central adiposity, dyslipidemia, skeletal muscle wasting and osteoporosis (De Bosscher & Haegeman, 2009; Rhen & Cidlowski, 2005; Rockall et al., 2003; Schacke et al., 2002, 2006).”
BackgroundWystrychowski, G., Wystrychowski, W., Grzeszczak, W., Więcek, A., Król, R., & Wystrychowski, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010221 · Cited by 9
“At the post-transcriptional level, steroids destabilize mRNA for inflammatory mediators (TNFα, IL-6, IL-1β) [22].”
BackgroundRanade, A. V., Hegde, P. S., Bhat, M. A., Rai, P., Vinodini, N. A., Aravind, A., Prasad, T. S. K., & Gowda, K. M. D. (2023) · Scientific Reports · doi:10.1038/s41598-023-38506-x · Cited by 8
Role of Nuclear Receptors in the Biliary Epithelium
Firrincieli, D., Zúñiga, S., Poupon, R. Y., Housset, C., & Chignard, N. (2011) · Digestive Diseases · doi:10.1159/000324129 · Cited by 9
“], the activation of VDR and FXR in biliary epithelial cells may provide protection against chronic inflammation triggered by endotoxins.Inflammation can be controlled by nuclear receptors such as the glucocorticoid receptor (GR), FXR or the peroxisome proliferator-activated receptors (PPARs) in various epithelial cel…”
BackgroundImmediate and delayed hypersensitivity to corticosteroids
Basedow, S., Eigelshoven, S., & Homey, B. (2011) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2011.07718.x · Cited by 9
Systemic use of non‐biologic corticosteroids in orofacial diseases
Georgakopoulou, E. A., & Scully, C. M. (2013) · Oral Diseases · doi:10.1111/odi.12132 · Cited by 11
Discovery of orally available tetrahydroquinoline-based glucocorticoid receptor agonists
Hudson, A. R., Higuchi, R. I., Roach, S. L., Adams, M. E., Vassar, A., Syka, P. M., Mais, D. E., Miner, J. N., Marschke, K. B., & Zhi, L. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.093 · Cited by 10
Bansal, A., Kooi, C., Kalyanaraman, K., Gill, S., Thorne, A. J., Chandramohan, P., Necker‐Brown, A., Mostafa, M., Milani, A., Leigh, R., et al. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000740 · Cited by 10
Kong, F., Laryea, G. N., Liu, Z., & Bhattacharyya, S. (2015) · Immunology · doi:10.1111/imm.12434 · Cited by 9
Role of glucocorticoids and Toxoplasma gondii infection on murine intestinal epithelial cells
Johnson, S. L., Gopal, R., Enriquez, A., & Monroy, F. P. (2014) · Parasitology International · doi:10.1016/j.parint.2014.05.005 · Cited by 8
Kadushkin, A. G., & Tahanovich, A. D. (2017) · PULMONOLOGIYA · doi:10.18093/0869-0189-2016-26-6-736-747 · Cited by 9
Leong, N. N. K., Brombacher, F., Dalpke, A. H., & Weitnauer, M. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.02.003 · Cited by 8
Cardiac Consequences of Anti-Inflammatory Drugs in Experimental Models
Merlet, N., Busseuil, D., Rhéaume, É., & Tardif, J. (2013) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523011312010005 · Cited by 7
“The antiinflammatory effects of GCs are mediated by genomic and non-genomic mechanisms [7].”
BackgroundPresman, D. M., Levi, V., Pignataro, O. P., & Pecci, A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.026 · Cited by 8
“In this sense, it has been proposed that GR–Hsp90 interaction with a ligand-bound GR mimics the receptor’s interaction with transcriptional co-activators (De Bosscher and Haegeman, 2009).”
BackgroundSun, Y., Narayan, V. A., & Wittenberg, G. M. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0090-9 · Cited by 8
“The immune-modulators and anti-inflammatory drugs sharing side effects with antidepressants in our study fall into two different categories: one targeting pathways such as glucocorticoid signaling, which is known to affect both immune and nervous systems; the other targeting mainly pro-inflammatory mediators such as c…”
BackgroundInfluentialPhysiology of the Adrenal Gland
(2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00568-6 · Cited by 7
Karakan, T., Kerem, M., Cindoruk, M., Engin, D., Alper, M., & Akın, O. (2013) · The Turkish Journal of Gastroenterology · doi:10.4318/tjg.2013.0605 · Cited by 7
“Inflammation of the biliary epithelium can be controlled by nuclear receptors such as the glucocorticoid receptor (GR), FXR, or the peroxisome proliferator-activated receptors (PPARs) in various epithelial cells (9-11).”
BackgroundSuresh, P. S., Thakur, K. G., & Sharma, U. K. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2003864 · Cited by 6
Baumann, G., Kinjo, M., & Földes‐Papp, Z. (2014) · Journal of Biological Methods · doi:10.14440/jbm.2014.17 · Cited by 6
“Upon ligand binding, GRα is translocated to the nucleoplasm in the nucleus, where it works either as a homodimer that binds to positive or negative glucocorticoid response elements (GRE) located in the promoter regions of target genes or as a monomer that cooperates with other transcription factors to induce transcrip…”
BackgroundNonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced PEPCK activation
Hudson, A. R., Higuchi, R. I., Roach, S. L., Valdez, L. J., Adams, M. E., Vassar, A., Rungta, D. K., Syka, P. M., Mais, D. E., Marschke, K. B., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.104 · Cited by 9
Bablok, M., Gellisch, M., Scharf, M., Brand‐Saberi, B., & Moroşan‐Puopolo, G. (2023) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2023.152056 · Cited by 6
Cartwright, M., Toit, R. L.-D., Jackson, H., van Vuuren, M. J., & Africander, D. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106348 · Cited by 9
“For the GR, however, the transrepression mechanism underlies the use of glucocorticoids as anti-inflammatories, as glucocorticoid-bound GR represses several inflammatory genes via this mechanism [79].”
BackgroundAntimicrobial and Anti‐Inflammatory Intelligent Surfaces
Griesser, H. J., Hall, H., Jenkins, A. T. A., Griesser, S. S., & Vasilev, K. A. (2012) · Wiley eBooks · doi:10.1002/9781118181249.ch6 · Cited by 9
Bertholf, R. L., Jialal, I., & Winter, W. E. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00054-8 · Cited by 5
Metadata
- Authors
- De Bosscher, K., & Haegeman, G.
- Affiliations
- Laboratory of Eukaryotic Gene Expression and Signal Transduction, Department of Physiology, Ghent University, 9000 Gent, Belgium
- Ghent University (BE)
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-03-01
- Volume
- 23
- Issue
- 3
- Pages
- 281-291
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC5428155
- OpenAlex
- W2092900546
- Cited by
- 284
- References
- 133
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 2 · 2023: 14 · 2022: 13 · 2021: 6 · 2020: 8 · 2019: 10 · 2018: 11 · 2017: 17 · 2016: 15 · 2015: 15 · 2014: 20 · 2013: 30 · 2012: 22
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Universiteit Gent
- Vlaamse regering
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoids, anti-inflammatory mechanism, glucocorticoid receptor, nuclear receptor cofactors, chromatin regulation, gene transcription, glucocorticoid adverse effects, cell type-specific gene regulation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Gene Expression Regulation, Glucocorticoids, Humans, Immunosuppressive Agents, Models, Biological, Receptors, Glucocorticoid, Repressor Proteins, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.